Primary biliary cholangitis (PBC), also known as primary biliary cirrhosis, is a chronic and progressive disease that damages and can eventually destroy the bile ducts of the liver. Researchers ...

Primary biliary cholangitis (PBC) is a rare liver disease. It blocks and destroys bile ducts in the liver. Doctors used to call it “primary biliary cirrhosis.” “Biliary” means bile.

Primary biliary cholangitis (PBC) causes chronic inflammation and progressive destruction of the bile ducts, resulting in cholestatic pruritus—a severe internal itch that scratching cannot relieve.

Primary biliary cholangitis (PBC) experts Thomas Berg, Michael Trauner, and Palak Trivedi discuss the current unmet needs in ...

If this continues, it can lead to serious liver problems and even liver failure. Primary biliary cholangitis, formerly known as primary biliary cirrhosis, is an autoimmune disease that causes ...

Liver disease is on the rise in the United States. Women are at a higher risk of developing a certain type of liver disease ...

“Our deep expertise in treating liver disease has delivered the first and only treatment for hepatitis delta and the first treatment for primary biliary cholangitis that has demonstrated ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical response in patients with primary biliary cholangitis. Results from an interim ...

In 2019, elafibranor was granted Breakthrough Therapy Designation by the U.S Food and Drug Administration (FDA) in adults with Primary Biliary Cholangitis (PBC) who have an inadequate response to ...

Primary biliary cholangitis (PBC) is a rare autoimmune disease affecting the bile ducts in the liver. When bile ducts become damaged, bile can build up in the liver, leading to inflammation and ...